The TRβ1 is essential in mediating T3 action on Akt pathway in human pancreatic insulinoma cells

Journal of Cellular Biochemistry

Volumn 106, Issue 5, 2009, Pages 835-848

  Falzacappa, Cecilia Verga ^a,b,c   Patriarca, Valentina ^a,b   Bucci, Barbara ^b   Mangialardo, Claudia ^a,b   Michienzi, Simona ^a,b   Moriggi, Giulia ^a,b   Stigliano, Antonio ^a,b   Brunetti, Ercole ^b   Toscano, Vincenzo ^a   Misiti, Silvia ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

^c DEM   (Italy)

Author keywords

Akt; Pancreatic cells; T3; Thyroid hormone receptors

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN BAD; PROTEIN KINASE B; S6 KINASE; THYROID HORMONE RECEPTOR BETA; LIOTHYRONINE;

ARTICLE; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INSULINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; HUMANS; INSULINOMA; PANCREATIC NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS C-AKT; THYROID HORMONE RECEPTORS BETA; TRIIODOTHYRONINE;

EID: 65349161564     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22045     Document Type: Article

References (34)

1. Ackermann AM, Gannon M. 2007. Molecular regulation of pancreatic β-cell mass development, maintenance and expansion. J Mol Endocrinol 38:193- 206.
2. Baroni MG, Cavallo MG, Mark M, Monetini L, Stoherer B. 1999. Beta-cell gene expression and functional characterization of the human insulinoma cell line C. J Endocrinol 161:59-68.
3. Barrera-Hernandez G, Soo Park K, Dace A, Zhan Q, Cheng SY. 1999. Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclin-dependent kinase levels and activity. Endocrinology 11 (140) :5267-5274.
4. Baumann CT, Maruvada P, Hager GL, Yen PM. 2001. Nuclear cytoplasmic shuttling by thyroid hormone receptors. Multiple protein interactions are required for nuclear retention. J Biol Chem 276:11237-11245.
5. Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ. 2005. Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146:2864-2871.
6. Bernal Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. 2001. Islet beta cell expression of constitutively active Akt/PKB alpha induces striking hypertrophy, hyperplasia and hyperinsulinemia. J Clin Invest 108:1631- 1638.
7. Cao X, Kambe F, Moeller LC, Refetoff S, Seo H. 2005. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Mol Endocrinol 19:102-112.
8. Cavallo MG, Dotta F, Monetini L, Dionisi S, Previti M, Valente L, Toto A, Di Mario U, Pozzilli P. 1996. Beta-cell markers and autoantigen expression by a human insulinoma cell line: Similarities to native beta cells. J Endocrinol 150 (1) :113-120.
9. Cavallo MG, Pozzilli P, Misiti S, Baroni MG. 2008. Insulinoma CM cell line as in vitro model for beta-cell. J Cell Physiol 216 (2) :568.
10. Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA, McCubrey JA. 2003. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis and neoplastic transformation: A target for cancer chemotherapy. Leukemia 17:590-603.
11. Cozar Castellano C, Fiaschi-Taesch N, Bigatel TA, Takane KK, Garcia-Ocaña A, Vasavada R, Stewart AF. 2006. Molecular control of cell cycle progression in the pancreatic p-cell. Endocr Rev 27 (4) :356-370.
12. Dickson LM, Rhodes CJ. 2004. Pancreatic P-cell growth and survival in the onset of type 2 diabetes: A role for protein kinase B in the Akt? Am J Physiol Endocrinol Metab 287:E192-E198.
13. Elghazi L, Balcazar N, Bernal-Mizrachi E. 2006. Emerging role of protein kinase B/Akt signalling in pancreatic β cell mass and function. Int J Biochem Cell Biol 38:689-695.
14. Furuya F, Hanover JA, Cheng Y. 2006. Activation of phosphatidylinositol 3- kinase signalling by a mutant thyroid hormone β receptor. Proc Natl Acad Sci 103 (6) :1780-1785.
15. Guigon CJ, Zhao L, Lu C, Willingham MC, Cheng SY. 2008. Regulatin of P- catenin by a novel nongenomic action of thyroid hormone β receptor. Mol Cell Biol 28 (14) :4598-4608.
16. Johnson JD, Ahmed NT, Luciani DS, Han Z, Tran H, Fujita J, Misler S, Edlund H, PolonskyKS. 2003. Increased islet apoptosis in Pdx1 ± mice. J Clin Invest 111:1147-1160.
17. Jonnakuty C, Gragnoli C. 2007. Karyotype of the human insulinoma CM cell line-beta cell model in vitro? J Cell Physiol 213:661-662, 207.
18. Kenessey A, Ojamaa K. 2006. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J Biol Chem 281 (30) :20666-20672.
19. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E, Slingerland JM. 2002. PKB /Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27- mediated G1 arrest. Nat Med 8:1153-1160.
20. Michienzi S, Bucci B, Verga Falzacappa C, Panacchia L, Patriarca V, Stigliano A, Brunette E, Toscano V, Misiti S. 2007. T3 inhibits ductal pancreatic adenocarcinoma proliferation improving the cytotoxic effect of chemotherapy. J Endocrinol 193 (2) :209-223.
21. Miller LD, ParkKS, Guo QM, Alkharouf NW, MalekRL, Lee NH, Liu ET, Cheng SY. 2001. Silencing of Wnt signaling and activation of multiple metabolic pathways in response to thyroid hormone-stimulated cell proliferation. Mol Cell Biol 21 (19) :6626-6639.
22. Misiti S, Anastasi E, Sciacchitano S, Verga Falzacappa C, Panacchia L, Bucci B, Khouri D, DAcquarica I, Brunetti E, Di Mario U, Toscano V, Perfetti R. 2005. 3, 5, 3'-triiodo-L-thyronine enhances the differentiation of a human pancreatic duct cell line into endocrine cells. J Cell Physiol 204 (1) :286-296.
23. Oetting A, Yen PM. 2007. New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab 21 (2) :193-208.
24. Olashaw N, Bagui TK, Pledger WJ. 2004. Cell cycle control: A complex issue. Cell Cycle 3 (3) :263-264.
25. Pende M, Kozma SC, Jaquet M, Oorschot V, Burcelin R, Le Marchand-Brustel Y, Kwperman J, Thorens B, Thomas G. 2000. Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature 408:994-997.
26. Pibiri M, Ledda-Columbano GM, Cossu C, Simula G, Menegazzi M, Shinozuka H, Columbano A. 2001. Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3). FASEB J 15:1006-1013.
27. Plateroti M, Kress E, Mori JI, Samarut J. 2006. Thyroid hormone receptor a1 directly controls transcription of the P-catenin gene in intestinal epithelial cells. Mol Cell Biol 2006. 3204-3214.
28. Sherr CJ, Roberts MJ. 1999. CDK inhibitors: Positive and negative regulators of the G1-phase progression. Genes Dev 13:1501-1512.
29. Kip1 at threonine 157 and modulation of its cellular localization. Nat Med 8:1145- 1152.
30. Tuttle RL, Gill NS, Pugh W, Cee JP, Koeberlein B, Furth EE. 2001. Regulation of pancreatic beta cell growth and survival by the serine/threonine protein kinase Akt1/PKB alpha. Nat Med 7:1133-1137.
31. Verga Falzacappa C, Panacchia L, Bucci B, Stigliano A, Cavallo MG, Brunetti E, Toscano V, Misiti S. 2006. 3, 5, 3'-triiodothyronine (T3) is a survival factor for pancreatic β-cells undergoing apoptosis. J Cell Physiol 206 (2) :309-321.
32. Verga Falzacappa C, Petrucci E, Patriarca V, Michienzi S, Stigliano A, Brunetti E, Toscano V, Misiti S. 2007. Thyroid hormone receptor TRp1 mediates Akt activation by T3 in pancreatic β-cells. J Mol Endocrinol 38 (1-2) :221-233.
33. HIP1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 8:1136-1144.
34. Woodgett JR. 2005. Recent advances in the protein kinase B signalling pathway. Curr Opin Cell Biol 17:150-157.